Public Profile

Lundbeck

Lundbeck, officially known as H. Lundbeck A/S, is a global pharmaceutical company headquartered in Denmark (DK). Founded in 1915, Lundbeck has established itself as a leader in the neuroscience sector, focusing on the treatment of brain disorders such as depression, schizophrenia, and Alzheimer's disease. With a strong presence in Europe, North America, and Asia, the company is dedicated to improving the lives of patients through innovative therapies. Lundbeck's core products include a range of unique medications that address complex neurological conditions, setting them apart in a competitive market. The company has achieved notable milestones, including the development of several breakthrough treatments that have significantly impacted patient care. Renowned for its commitment to research and development, Lundbeck continues to strengthen its position as a key player in the global pharmaceutical industry.

DitchCarbon Score

How does Lundbeck's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

93

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Lundbeck's score of 93 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

100%

Let us know if this data was useful to you

Lundbeck's reported carbon emissions

In 2023, Lundbeck reported total greenhouse gas emissions of approximately 13,314,000 kg CO2e, comprising 11,314,000 kg CO2e from Scope 1 and 1,845,000 kg CO2e from Scope 2 emissions. The company has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 emissions by 63% by 2034 from a 2019 baseline. Additionally, Lundbeck targets a 19% reduction in absolute Scope 3 emissions by the same year. Lundbeck's long-term goal is to achieve net-zero greenhouse gas emissions across its entire value chain by 2050. This includes a commitment to reduce absolute Scope 1, 2, and 3 emissions by 90% from 2019 levels by 2050. Near-term targets also include a 42% reduction in Scope 1 and 2 emissions and a 25% reduction in specific Scope 3 emissions by 2029. These commitments align with industry standards for climate action, reflecting Lundbeck's dedication to sustainability and responsible environmental stewardship.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2018201920202021202220232024
Scope 1
-
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
-
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 3
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Lundbeck's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Lundbeck is in DK, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Lundbeck is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Astra Zeneca

GB
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Luye Pharma

CN
Pharmaceutical Preparation Manufacturing
Updated about 14 hours ago

Sanofi

FR
Pharmaceutical Preparation Manufacturing
Updated about 14 hours ago

Meda AB

SE
Pharmaceutical Preparation Manufacturing
Updated about 21 hours ago

Glaxosmithkline

GB
Pharmaceutical Preparation Manufacturing
Updated about 13 hours ago

Pfizer

US
Pharmaceutical Preparation Manufacturing
Updated about 14 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers